MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
12.80
+0.25 (1.99%)
Sep 22, 2026, 12:47 PM EDT - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $1.09 billion as of September 22, 2026. Its market cap has decreased by -68.10% in one year.
Market Cap
1.09B
Enterprise Value
653.87M
1-Year Change
-68.10%
Ranking
Category
Stock Price
$12.80
ChartMarket Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.09B, an increase of 30,176.31%. That is a compound annual growth rate of 245.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.09B | 15.80% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Obsidian Therapeutics | 1.10B |
| Jade Biosciences | 1.08B |
| Corvus Pharmaceuticals | 1.06B |
| Kura Oncology | 1.04B |
| Monte Rosa Therapeutics | 1.03B |
| Janux Therapeutics | 1.01B |
| Adlai Nortye Group | 1.01B |
| Attovia Therapeutics | 1.01B |